Categories Health Care, U.S. Markets News
Thailand legalizes medical use of cannabis, opens up a new region for pot stocks
After Uruguay and Canada, Thailand has now amended its drug law to legalize marijuana for medical purposes. However, unlike the other two counties, legalization does not apply to recreational use.
After the parliament voted to push the bill, one of its lawmakers called it a “New Year gift to the Thai people.”
Ironically, South East Asia is a region that prescribes the toughest penalties for drug-related offenses. In Indonesia, Singapore, and Malaysia, weed-related offenses may lead up to capital punishment.
This is great news for companies involved in medical marijuana research including Tilray (TLRY), Canopy Growth (CGC), Aphria Inc (APHA), Innovative Industrial Properties (IIPR) and KushCo Holdings (KSHB). The companies currently concentrate most of their in Canada, where marijuana was legalized in October this year.
Shares of most cannabis stocks opened higher on Wednesday during pre-market trading.
The legalization not only opens up a new market for these companies but also a gateway to a much bigger region.
According to the Bangkok Post, pot users will be allowed to carry only prescribed amounts that are required for medical use. The consumers will also need to furnish a recognized certificate to authorities as sale and production of weed will be in a controlled manner.
Aurora Cannabis eyes 130-mn market through Mexican firm acquisition
Research shows that marijuana is effective in pain relief, besides the treatment of nausea caused due to chemotherapy. Clinical studies are underway to study the other medical applications of marijuana.
Get access to timely and accurate verbatim transcripts that are published within hours of the event
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was
Comments